US FDA approves AbbVie's drug for Parkinson's disease

The ​US Food ‌and ​Drug ​Administration has ⁠approved ​AbbVie's drug ​for Parkinson's ​disease ​in adults, the ‌health ⁠regulator's website ​showed ​on ⁠Friday.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。